跳至主導覽
跳至搜尋
跳過主要內容
慈濟大學學研人才庫 首頁
帳號申請/資料更新
連結會在新分頁中打開
English
中文
在 慈濟大學學研人才庫 搜尋內容
首頁
專家檔案
研究單位
研究成果
貴重儀器
研究計畫
獎項
活動
新聞/媒體
學士後中醫學系(含碩士班)
慈濟大學
醫學院
郵寄地址
台灣
概覽
指紋
網路
專家檔案
(16)
研究計畫
(2)
研究成果
(833)
活動
(1)
新聞/媒體
(3)
指紋
查看啟用 學士後中醫學系(含碩士班) 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Gastroesophageal Reflux
100%
Reflux
89%
Chronic Kidney Disease
68%
Peristalsis
67%
Esophagus Motility
65%
High Resolution Manometry
54%
Diseases
47%
Chinese Herbal Medicine
46%
Traditional Chinese Medicine
44%
Endovascular Surgery
42%
Cohort Analysis
38%
Acupuncture
38%
Hazard Ratio
36%
Infusion
35%
Arteriosclerosis Obliterans
34%
Uremic Pruritus
32%
Hepatocellular Carcinoma
31%
Meta-Analysis
31%
Artery Disease
29%
Cardiovascular Disease
29%
Systematic Review
28%
Critical Limb Ischemia
28%
Retrospective Cohort Study
27%
Acupuncture Point
25%
Anemia
24%
Rheumatoid Arthritis
24%
Inflammatory Arthritis
24%
Cardiovascular System
23%
Restenosis
22%
Odds Ratio
22%
Randomized Controlled Trial
21%
Injection
21%
Patient with Gastroesophageal Reflux
21%
Limb
21%
Maturity Onset Diabetes of the Young
21%
Diabetes
20%
Hypervigilance
19%
Apoplexy
18%
Paclitaxel
18%
Atrial Fibrillation
18%
Endoscopy
18%
Programmed Cell Death
17%
Prevalence
17%
Reflux Esophagitis
16%
Proton-Pump Inhibitor
16%
Overall Survival
15%
Clinical Trial
15%
Liver Cirrhosis
14%
Vegetarian Diet
14%
Inflammation
14%
Prospective Cohort Study
14%
Diabetes Mellitus
14%
Straight Leg Raise
14%
Angioplasty
14%
Placebo
13%
Indican
13%
Systemic Lupus Erythematosus
13%
Network Meta-Analysis
13%
QTc Interval
13%
Thrombosis
13%
Hematinic
13%
Heartburn
13%
Revascularization
11%
Manometry
11%
Pulse Rate
11%
Area under the Curve
11%
Body Mass Index
11%
Brain Ischemia
10%
Acute Kidney Injury
10%
All Cause Mortality
10%
COVID-19
10%
Treatment Outcome
10%
Vascular Access
10%
Infection
10%
Cardiovascular Risk
10%
Biological Marker
10%
Liver Tumor
10%
End Stage Renal Disease
10%
Insulin Dependent Diabetes Mellitus
10%
Amputation
10%
Fingertip
9%
Proportional Hazards Model
9%
Percutaneous Transluminal Angioplasty
9%
Cohort Studies
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Protein Kinase B
9%
Breast Cancer
9%
Colorectal Carcinoma
9%
Vegan Diet
9%
Inflammatory Cytokine
9%
Retrospective Study
9%
Neoplasm
9%
Hemoglobin
9%
Chronic Hepatitis B
9%
Decoction
9%
Traumatic Brain Injury
9%
Capsaicin
9%
Climacterium
9%
Entropy
9%
Wound
9%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
77%
Cohort Study
63%
Traditional Chinese Medicine
57%
Inflammation
55%
Liver Cell Carcinoma
54%
Diseases
43%
Protein Kinase B
40%
Doxorubicin
39%
Rat
38%
Hemodialysis
35%
Inflammatory Arthritis
34%
Rheumatoid Arthritis
34%
Cardiovascular Disease
32%
Malignant Neoplasm
32%
Peripheral Occlusive Artery Disease
30%
Randomized Controlled Trial
30%
Colorectal Carcinoma
28%
Pruritus
27%
Anemia
26%
Reactive Oxygen Metabolite
25%
Lung Cancer
24%
Western Blot
24%
Hydrogen Peroxide
24%
Brain Ischemia
23%
microRNA
23%
Antioxidant
22%
Heart Ventricle Hypertrophy
21%
Infection
19%
Nonalcoholic Fatty Liver
19%
Heart Injury
19%
Antianemic Agent
18%
Cell Viability
18%
Glucose
18%
Galactose
18%
Zebra Fish
18%
Gemcitabine
18%
Chronic Hepatitis C
18%
Natural Product
18%
Cytokine
17%
Cardiotoxicity
17%
Hypertension
17%
Diabetes Mellitus
16%
SARS Coronavirus
16%
Hepatitis C
16%
Mouse Model
16%
Neoplasm
16%
Liver Cirrhosis
16%
Biological Marker
15%
Gelatinase B
15%
Nuclear Factor
15%
Interleukin 6
15%
Indican
15%
Therapeutic Effect
15%
Hepatitis B
15%
Spontaneously Hypertensive Rat
14%
End Stage Renal Disease
14%
Transcription Factor AP 1
14%
Chronic Hepatitis B
13%
Ovary Cancer
13%
Urodela
13%
Aristolochic Acid
13%
Artemisia argyi
13%
Peroxisome Proliferator Activated Receptor
13%
Acupuncture Point
13%
Somatomedin
13%
Protein Tyrosine Kinase Inhibitor
13%
Anti-Inflammatory Drug
13%
Acute Lung Injury
13%
Lipopolysaccharide
13%
Mitogen Activated Protein Kinase 3
12%
Tumor Necrosis Factor
12%
Atrial Fibrillation
11%
All Cause Mortality
11%
Ribavirin
11%
Phosphotransferase
10%
Liver Disease
10%
Flow Cytometry
10%
Prospective Cohort Study
10%
Progression Free Survival
10%
Overall Survival
10%
Fatty Liver
10%
Phthalic Acid Bis(2 Ethylhexyl) Ester
10%
Nerolidol
9%
12-O-Tetradecanoylphorbol-13-Acetate
9%
Phosphatidylinositol 3 Kinase
9%
Hemoglobin
9%
Receptor
9%
Lenvatinib
9%
Sorafenib
9%
Neovascularization (Pathology)
9%
Alternative Complement Pathway C3 C5 Convertase
9%
Nervous System Inflammation
9%
Liver Fibrosis
9%
Critical Limb Ischemia
9%
Transgenic Mouse
9%
Folic Acid
9%
Amyloid Beta Protein
9%
Deterioration
9%
Lactobacillus reuteri
9%
Folinic Acid
9%
Immunology and Microbiology
Hepatitis C
39%
Infectious Disease
32%
Infection
32%
Kinase
24%
Phosphotransferase
24%
Hepatitis B
22%
Inflammatory Arthritis
22%
Body Mass
22%
Rat
21%
Programmed Cell Death
20%
Ribavirin
19%
Hepatitis C Virus
19%
Inflammation
18%
Lung
18%
Asthma
18%
Tyrosine
15%
Prevalence
14%
Ribonucleic Acid
14%
Urodela
13%
Severe Acute Respiratory Syndrome Coronavirus 2
13%
Promoter Region
13%
Adipose Derived Stem Cell
13%
Hydrogen Peroxide
13%
Colorectal Carcinoma
13%
Pegylated Interferon
12%
Insulin Resistance
11%
Viral Load
10%
Drug Resistance
10%
Pretreatment
10%
Glucose Blood Level
10%
Susceptibility
10%
DNA Polymorphism
10%
High-Density Lipoprotein
9%
In Vitro
9%
Cholesterol Blood Level
9%
Non-Alcoholic Fatty Liver Disease
9%
Avian orthoreovirus
9%
Hericium erinaceus
9%
Mononuclear Cell
9%
Somatomedin
9%
Hemodialysis
9%
Lactobacillus reuteri
9%
Synoviocyte
9%
Epithelial Mesenchymal Transition
9%
Imiquimod
9%
Hepatitis B Virus
8%
Alanine Aminotransferase Level
8%
Interleukin 6
8%
Viral Clearance
8%
Cancer Cell
7%
Western Blot
7%
Overall Survival
7%
Progression Free Survival
7%
COVID-19
7%
Hepatitis C Virus Genotype 1
7%
Oxidative Stress
7%
Low-Density Lipoprotein
7%
Signal Transduction
7%
Cell Survival
6%
Mouse Model
6%
Interferon Type I
6%
Stem Cell
6%
Phosphatase
6%
C-Reactive Protein
6%
Dioxygen
6%
Transcription Factor Nrf2
6%
Mesenchymal Stem Cell
6%
Alanine
6%
Protein Expression
5%
Blood Pressure
5%
Hepatitis Virus
5%
Tumor Necrosis Factor
5%
Cytokine Signaling
5%
Cirrhosis
5%
Glucose
5%
Inflammatory Cytokine
5%
STAT3
5%
Peginterferon Alpha
5%
Cell Cycle
5%
Wharton Jelly
5%
Lentivirus
5%
Inflammation Response
5%
Autophagy
5%
Spike Protein
5%